Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
68.48
Dollar change
+0.53
Percentage change
0.78
%
IndexS&P 500 P/E10.33 EPS (ttm)6.63 Insider Own0.18% Shs Outstand1.30B Perf Week-1.35%
Market Cap88.13B Forward P/E8.05 EPS next Y8.51 Insider Trans-1.02% Shs Float1.28B Perf Month-0.36%
Income8.60B PEG2.58 EPS next Q1.97 Inst Own79.25% Short Float / Ratio1.23% / 2.16 Perf Quarter4.28%
Sales348.19B P/S0.25 EPS this Y-1.22% Inst Trans0.59% Short Interest15.84M Perf Half Y-2.16%
Book/sh57.76 P/B1.19 EPS next Y-0.85% ROA3.56% Target Price86.72 Perf Year-32.78%
Cash/sh12.65 P/C5.41 EPS next 5Y4.00% ROE11.86% 52W Range64.41 - 104.83 Perf YTD-26.52%
Dividend2.36 P/FCF7.80 EPS past 5Y-13.40% ROI5.71% 52W High-34.68% Beta0.53
Dividend %3.45% Quick Ratio0.64 Sales past 5Y12.22% Gross Margin15.72% 52W Low6.32% ATR1.41
Employees300000 Current Ratio0.86 Sales Q/Q10.63% Oper. Margin4.49% RSI (14)48.69 Volatility1.96% 1.91%
OptionableYes Debt/Eq1.08 EPS Q/Q167.47% Profit Margin2.47% Rel Volume0.97 Prev Close67.95
ShortableYes LT Debt/Eq1.03 EarningsNov 01 BMO Payout71.91% Avg Volume7.33M Price68.48
Recom1.52 SMA20-0.37% SMA50-1.52% SMA200-4.87% Volume7,084,824 Change0.78%
Date Action Analyst Rating Change Price Target Change
Sep-19-23Upgrade Evercore ISI In-line → Outperform $81 → $83
Sep-12-23Upgrade Wolfe Research Peer Perform → Outperform $80
Aug-18-23Downgrade Edward Jones Buy → Hold
May-26-23Initiated Piper Sandler Overweight $85
Apr-21-23Initiated Cantor Fitzgerald Overweight $87
Jan-03-23Downgrade Evercore ISI Outperform → In-line $120 → $100
Nov-23-22Resumed Morgan Stanley Overweight $124 → $119
Jun-17-22Initiated Loop Capital Buy $120
May-27-22Downgrade Bernstein Outperform → Mkt Perform $122 → $112
Mar-29-22Downgrade Deutsche Bank Buy → Hold $110
Dec-01-23 11:31AM
09:54AM
Nov-30-23 04:20PM
02:39PM
Nov-29-23 07:46PM
06:04PM Loading…
06:04PM
04:28PM
01:46PM
10:05AM
05:21AM
01:12AM
Nov-28-23 02:11AM
Nov-27-23 11:46AM
11:46AM
Nov-26-23 06:51AM
03:05AM Loading…
Nov-24-23 03:05AM
Nov-23-23 12:50PM
Nov-22-23 08:00AM
Nov-21-23 09:00AM
Nov-16-23 03:44PM
01:27PM
12:05PM
Nov-15-23 10:07AM
08:00AM
Nov-14-23 04:53PM
Nov-13-23 10:41AM
Nov-09-23 06:12AM
Nov-08-23 04:52PM
11:53AM
Nov-07-23 09:00AM
09:00AM Loading…
09:00AM
Nov-06-23 03:17PM
Nov-03-23 08:30AM
05:34AM
Nov-02-23 09:00PM
06:30PM
01:17PM
06:04AM
05:50AM
Nov-01-23 11:36PM
05:35PM
03:09PM
02:18PM
12:53PM
12:30PM
12:27PM
11:30AM
11:20AM
11:07AM
10:37AM
10:06AM
09:58AM
09:54AM
09:35AM
09:30AM
09:14AM
09:01AM
08:21AM
07:37AM
07:34AM
07:14AM
06:44AM
06:36AM
06:30AM
06:30AM
Oct-30-23 04:45PM
12:44PM
11:53AM
11:39AM
09:30AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
07:59AM
06:35AM
05:46AM
Oct-29-23 09:00PM
05:23PM
Oct-27-23 07:28PM
04:10PM
Oct-26-23 09:00AM
07:00AM
Oct-25-23 11:58AM
11:43AM
10:02AM
09:00AM
06:00AM
Oct-24-23 05:45PM
11:02AM
07:48AM
Oct-23-23 09:54AM
Oct-22-23 08:00AM
Oct-20-23 03:36PM
01:40PM
12:23PM
11:00AM
09:14AM
07:30AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions. The Retail or Long-Term Care segment includes the sale of prescription drugs and an assortment of health and wellness products, and general merchandise. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, Medicare Part D prescription drug plan, Medicaid health care management services, and health information technology products and services. The Corporate and Other segment is involved in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LUDWIG EDWARD JDirectorNov 03Buy70.472,000140,93020,630Nov 06 10:59 AM
Clark James DavidSVP, Cont & Chief Acct OfficerAug 03Sale74.9225,7591,930,0044,698Aug 04 05:41 PM
Lynch Karen SPresident and CEOMay 03Buy69.7514,000976,567431,392May 05 08:27 AM
Moriarty Thomas MEVP & General CounselDec 15Option Exercise73.85137,46610,151,220709,105Dec 16 04:14 PM
Moriarty Thomas MEVP & General CounselDec 15Sale98.36137,46613,521,180608,129Dec 16 04:14 PM